Health Canada has granted a medical device licence for Cepheid’s Xpert HCV VL Fingerstick, a test used to detect and quantify the hepatitis C virus (HCV) from a single blood drop.

This advancement is set to streamline the diagnostic process, facilitating faster access to treatment and monitoring of the virus.

The fingerstick test aids in diagnosing patients at an elevated risk of HCV infection or those who have already tested positive for anti-HCV antibodies. It is also useful in managing individuals with HCV who are receiving antiviral therapy.